⌘K

Login Start Free

Home/Filings/4/0001213900-19-018196

4//SEC Filing

Hexter Joshua 4

Accession 0001213900-19-018196

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 6:04 PM ET

Size

5.4 KB

Accession

0001213900-19-018196

Insider Transaction Report

Form 4

Period: 2019-09-12

ORAMED PHARMACEUTICALS INC.ORMP

COO & CBO

Transactions

Award
Stock option (right to buy)
2019-09-12+100,000→ 100,000 total
Exercise: $3.69Exp: 2029-09-12→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The Stock Options will vest in 16 equal installments of 6,250 on the first day of every three month period beginning November 1, 2019.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001573235

Filing Metadata

Form type: 4
Filed: Sep 15, 8:00 PM ET
Accepted: Sep 16, 6:04 PM ET
Size: 5.4 KB

View on SEC.gov